¡Ya estamos en ! Descubre más

Zoetis

ZTS

Capitalización de mercado USD 32.8 mil M

79.38 USD

+0.96

1.22%

Al cierre Actualizado 16 oct, 4:00 p.m. EDT

Antes de la apertura del mercado

Después del cierre del mercado

80.00

+0.62

0.78%

1 día

1.22%

5 días

5.84%

1 mes

8.74%

3 meses

3.21%

6 meses

-33.32%

En lo que va del año

-36.96%

1 año

-44.59%

5 años

-60.84%

10 años

58.66%

Acerca de: Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 30% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 70% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Empleados: 14,500

Atención médica Fabricantes de medicamentos especializados y genéricos

Noticias

Positivo

Neutral

Negativo

Sentimiento 3 meses

Positivo 21.5%

Neutral 68.4%

Negativo 10.1%

Zoetis Appoints Iris Knobloch to its Board of Directors

PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) today announced the appointment of Iris Knobloch to its Board of Directors, effective as of December 1, 2026. With decades of experience across global media and consumer businesses, Ms. Knobloch brings a distinct combination of international leadership, proven public company board experience across financial services, hospitality and media, and deep consumer and digital expertise to the Zoetis Board. She currently serves on the boards of.

Zoetis Appoints Iris Knobloch to its Board of Directors

10 Dividend Growth Stocks: October 2026

In this monthly series, I rank a selection of dividend growth stocks and present the top 10 stocks for consideration. This month's screen targets dividend growth stocks with Dividend Safety scores ≥8.0, forward yields ≥2.5%, and prices at or below fair value. An equally weighted portfolio of the top 10 stocks yields 2.8% but would have underperformed SPY over the past 5 years.

10 Dividend Growth Stocks: October 2026

Top 50 High-Quality Dividend Growth Stocks For October 2026

I track an investable universe of 50 high-quality dividend growth stocks to identify attractive entry points based on valuation and future return potential. Applied Materials, D.R. Horton, and Home Depot saw notable ranking improvements due to upgraded EPS growth estimates and/or favorable valuation shifts. 44 out of 50 stocks currently offer a forward return estimate of at least 10%, with 32 appearing potentially undervalued based on free cash flow mean reversion.

Top 50 High-Quality Dividend Growth Stocks For October 2026

Zacks Investment Research

Zoetis (ZTS) Outpaces Stock Market Gains: What You Should Know

In the most recent trading session, Zoetis (ZTS) closed at $74.81, indicating a +2.37% shift from the previous trading day.

Zoetis (ZTS) Outpaces Stock Market Gains: What You Should Know

The Motley Fool

A Once-in-a-Decade Opportunity: 2 Magnificent Dividend Stocks Down 34% to 52% I'm Buying Right Now

Both stocks are home to niche-leading businesses. However, each has run into some cyclicality in sales.

A Once-in-a-Decade Opportunity: 2 Magnificent Dividend Stocks Down 34% to 52% I'm Buying Right Now

Zoetis Declares Fourth Quarter 2026 Dividend

PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.53 per share for the fourth quarter of 2026. The dividend will be paid on Tuesday, December 1, 2026, to all holders of record of the Company's common stock as of the close of business on Friday, October 30, 2026. About Zoetis Zoetis is the world's leading animal health company, driven by a singular purpose: to nurture our world and humankind by advancing care for animals. With a leg.

Zoetis Declares Fourth Quarter 2026 Dividend

New Peer-Reviewed Publication on Laboratory Study That Demonstrated Simparica Trio® Protected 3x More Dogs From Infection With a Resistant Heartworm Isolate Than NexGard® Plus1

PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Drug-resistant heartworm is a growing concern for veterinarians and pet owners as resistant heartworm populations emerge. New research shows that not all heartworm preventives perform equally against these resistant isolates. Macrocyclic lactone (ML) resistance means some heartworm isolates are less sensitive to the drug class used in today's heartworm disease preventives. As ML resistance continues to challenge heartworm prevention, veterinarians need data th.

New Peer-Reviewed Publication on Laboratory Study That Demonstrated Simparica Trio® Protected 3x More Dogs From Infection With a Resistant Heartworm Isolate Than NexGard® Plus1

Zacks Investment Research

Zoetis (ZTS) Stock Sinks As Market Gains: Here's Why

Zoetis (ZTS) reached $69.1 at the closing of the latest trading day, reflecting a -1.05% change compared to its last close.

Zoetis (ZTS) Stock Sinks As Market Gains: Here's Why

Top 25 High-Growth Dividend Stocks For October 2026

The October 2026 Top 25 High-Growth Dividend Stocks list targets quality companies trading 31% below intrinsic value, with a projected 22.53% annual return. The list's average starting dividend yield is 1.51%, and the companies have grown dividends at 18.81% annually over five years. Stocks are categorized into Deep Value, Growth At A Price, and Balanced Opportunities, supporting diverse investment strategies based on valuation and growth.

Top 25 High-Growth Dividend Stocks For October 2026

Top 25 Attractive Dividend Stocks For October 2026

I present a rigorously screened Top 25 U.S. dividend growth stock list for October 2026, emphasizing fundamental growth, economic moats, and yields above 2.5%. The Top 25 stocks average a 3.38% dividend yield and appear ~31% undervalued by dividend yield theory, with an estimated 18.56% future CAGR. Subsets highlight high-yield, fast dividend growth, highest expected return, most undervalued, and fastest fundamental growth opportunities for targeted portfolio construction.

Top 25 Attractive Dividend Stocks For October 2026

Ver rankings de noticias

Gráficos de precios implementados con Lightweight Charts™